Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

IGI Laboratories Announces the Submission of Two More ANDAs

Eddie Staley, Benzinga Staff Writer
June 29, 2012 4:00 PM
+ Follow
Print
Email
Tickers: IG
Benzinga Share:

IGI Laboratories, Inc. (NYSE: IG) today announced that it has submitted two additional abbreviated new drug applications (ANDAs) to the US FDA, bringing the company's total number of submissions to eight.

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted in: News, FDA

 

Around the Web, We're Loving...

Check Out Our Investing 101 Course, Now 92% Off!
DC is doing nothing to fix the economy
NYT: Fox Case Proves Obama Administration Has No Respect for Press
Target's Q1 profit drops 26 pct on weak sales
What You Should Know About GOOG

Most Popular

Powerful Breakout May Be Setting Up in Molycorp
The Top 10 Notable Quotes from Apple's Senate Statement
JC Penney Reports Successful Early Tender Offer, Consent Solicitation Results for Debentures
ETFs to Watch May 21, 2013 (BOND, FEZ, NUGT)
Target Drops Wii U Price Ahead of Xbox Unveiling
Benzinga Market Primer: Tuesday, May 21

Related Articles (IG)

Partner Network

Get Benzinga's News Delivered Free

Posts by Eddie Staley

Benzinga Professional

Subscribe